Citation, commencement and interpretation1.
(1)
These Regulations may be cited as the Medicines for Human Use (Fees Amendments) (No. 2) Regulations 2005 and shall come into force—
(a)
except for the purposes of regulation 2(c), regulation 2(g) insofar as it inserts a definition of “Regulation (EC) No. 726/2004”, and regulations 3(b) and (d), on 16th November 2005; and
(b)
for the purposes of regulation 2(c), regulation 2(g) insofar as it inserts a definition of “Regulation (EC) No. 726/2004”, and regulations 3(b) and (d), on 20th November 2005.
(2)
In these Regulations “the General Fees Regulations” means the Medicines (Products for Human Use—Fees) Regulations 19957.